4
Changes in Ownership
Pyxis Oncology, Inc. Filed Acc 0001209191-23-047384
Options or other derivatives
- Director acquired 26,663 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Dupont Jakob Director | 2023-08-23 | Grant or award · Stock Option (Right to buy) | +5,879 | 5,879 | D | ||
| Dupont Jakob Director | 2023-08-23 | Grant or award · Stock Option (Right to buy) | +3,534 | 3,534 | D | ||
| Dupont Jakob Director | 2023-08-23 | Grant or award · Stock Option (Right to buy) | +17,250 | 17,250 | D | ||
Loading xslF345X05/doc4.xml…